IBDEI0XE ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16488,1,4,0)
 ;;=4^788.30
 ;;^UTILITY(U,$J,358.3,16488,1,5,0)
 ;;=5^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,16488,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,16489,0)
 ;;=V13.01^^92^938^25
 ;;^UTILITY(U,$J,358.3,16489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16489,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,16489,1,5,0)
 ;;=5^Hx Of Kidney Stone
 ;;^UTILITY(U,$J,358.3,16489,2)
 ;;=^303403
 ;;^UTILITY(U,$J,358.3,16490,0)
 ;;=302.71^^92^938^36
 ;;^UTILITY(U,$J,358.3,16490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16490,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,16490,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,16490,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,16491,0)
 ;;=596.54^^92^938^38
 ;;^UTILITY(U,$J,358.3,16491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16491,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,16491,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,16491,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,16492,0)
 ;;=788.43^^92^938^39
 ;;^UTILITY(U,$J,358.3,16492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16492,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,16492,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,16492,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,16493,0)
 ;;=605.^^92^938^42
 ;;^UTILITY(U,$J,358.3,16493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16493,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,16493,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,16493,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,16494,0)
 ;;=601.0^^92^938^44
 ;;^UTILITY(U,$J,358.3,16494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16494,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,16494,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,16494,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,16495,0)
 ;;=590.10^^92^938^46
 ;;^UTILITY(U,$J,358.3,16495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16495,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,16495,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,16495,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,16496,0)
 ;;=590.00^^92^938^47
 ;;^UTILITY(U,$J,358.3,16496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16496,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,16496,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,16496,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,16497,0)
 ;;=788.7^^92^938^54
 ;;^UTILITY(U,$J,358.3,16497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16497,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,16497,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,16497,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,16498,0)
 ;;=131.02^^92^938^57
 ;;^UTILITY(U,$J,358.3,16498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16498,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,16498,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,16498,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,16499,0)
 ;;=597.80^^92^938^55
 ;;^UTILITY(U,$J,358.3,16499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16499,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,16499,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,16499,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,16500,0)
 ;;=788.41^^92^938^58
 ;;^UTILITY(U,$J,358.3,16500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16500,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,16500,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,16500,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,16501,0)
 ;;=788.31^^92^938^62
 ;;^UTILITY(U,$J,358.3,16501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16501,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,16501,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,16501,2)
 ;;=^260046
